MedTrace Logo

Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)

NCT00996086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2019-02-04

No results posted yet for this study

Summary

This is an observational study to learn which patients benefit from CRT therapy and to track the clinical changes that help identify the risk-level of CRT patients.

Conditions

Interventions

DEVICE

CRT device implant

CRT device-recipients

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • VA Pittsburgh Healthcare System

    collaborator FED

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Alan Kadish, M.D. · Northwestern University

  • Alaa Shalaby, M.D. · VA Pittsburgh Healthcare System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996086 on ClinicalTrials.gov